CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP,General Counsel, Secretary sold 803 shares at $18.78 ($15,080)
- 4 Open-market sale EVP, COO, Head of Commercial sold 461 shares at $18.78 ($8,658)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 12,500 shares at $18.25 ($228,125)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Director acquired 30,000 shares (option exercise)
- 4 Open-market sale CEO sold 3,904 shares at $17.13 ($66,877)
- 4 Open-market sale EVP, COO, Head of Commercial sold 532 shares at $17.13 ($9,113)
- 4 Open-market sale EVP,General Counsel, Secretary sold 589 shares at $17.13 ($10,090)
- 4 Open-market sale President sold 1,847 shares at $15.07 ($27,834)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Open-market sale President sold 1,326 shares at $15.81 ($20,964)
Page 14 of 70 · 1,382 filings